See why OncoArendi Therapeutics chose Monolith MST for measuring binding affinities

3 reasons OncoArendi Therapeutics chose Monolith MST for measuring binding affinities:
1. They needed a tool that was able to detect the binding of small molecules
2. They wanted an immobilization-free method so they could measure interactions in a solution rather than on a surface
3. They needed to use as little sample material as possible and were able to use a low sample concentration

Previous Video
Prometheus Application Academy | PR.Stability Analysis software Display 101 tutorial
Prometheus Application Academy | PR.Stability Analysis software Display 101 tutorial

One of the challenges many scientists face is how to best present their data. No matter how stunning and gr...

Up next
PR.ChemControl for Prometheus Instruments
PR.ChemControl for Prometheus Instruments

Effortless chemical unfolding data acquisition and analysis in seconds, with fully automatic ΔGapp and Cm d...